Publicacions (71) Publicacions de JOSE BERNARDINO DIAZ LOPEZ

2024

  1. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

2019

  1. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

    Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106

  2. The Big Data Sjögren consortium: A project for a new data science era

    Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23

2018

  1. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)

    Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111

  2. Severe, life-threatening phenotype of primary Sjögren's syndrome: Clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)

    Clinical and Experimental Rheumatology, Vol. 36, pp. S121-S129

2017

  1. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort

    Autoimmunity Reviews, Vol. 16, Núm. 8, pp. 796-802

2016

  1. Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355

2014

  1. Association of matrix Gla protein gene functional polymorphisms with loss of bone mineral density and progression of aortic calcification

    Osteoporosis International, Vol. 25, Núm. 4, pp. 1237-1246

  2. Bilateral scalp necrosis in a patient with giant-cell arteritis

    Medicina Clinica, Vol. 142, Núm. 1, pp. 46

  3. Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 spanish patients (GEAS-SS registry)

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 321-331

2013

  1. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus

    The Scientific World Journal, Vol. 2013

  2. Metabolismo óseo y vascular: Impacto de la enfermedad renal crónica

    Actualizaciones en Osteologia, Vol. 9, Núm. 1, pp. 65-78

2012

  1. Low calcidiol levels and risk of progression of aortic calcification

    Osteoporosis International, Vol. 23, Núm. 3, pp. 1177-1182

2011

  1. Vascular calcification in patients with chronic kidney disease: Types, clinical impact and pathogenesis

    Medical Principles and Practice, Vol. 20, Núm. 3, pp. 203-212

2009

  1. Bone mineral density determination methods

    Revista Clinica Espanola, Vol. 209, Núm. SUPPL. 1, pp. 15-22

  2. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 24, Núm. 1, pp. 239-246

2008

  1. Lupus eritematoso sistémico o eclampsia

    Medicina Clinica

  2. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures

    Osteoporosis International, Vol. 19, Núm. 8, pp. 1161-1166

  3. ¿Ha cambiado la epidemiología de la osteoporosis en la última década?

    Medicina Clinica Monografias, Vol. 9, Núm. 7, pp. 3-8

2007

  1. Leucoencefalopatía posterior reversible y lupus eritematoso sistémico

    Medicina Clinica